Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.60 |
| ▸ | GAA | P10253 | 2/20 | 0.60 |
| ▸ | NPC1 | O15118 | 1/20 | 0.60 |
| ▸ | RAB9A | P51151 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | BLM | P54132 | 1/20 | 0.59 |
| ▸ | AGER | Q15109 | 1/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | PKM | P14618 | 1/20 | 0.58 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11504619 | 0.98 | ALDH1A1 (0.60) | ALDH1A1CYP2C9KDM4ETDP1SMN1; SMN2 | |
| SCHEMBL8371363 | 0.92 | ALDH1A1 (0.58) | ALDH1A1CYP2C9KDM4ETDP1SMN1; SMN2 | |
| SCHEMBL8370248 | 0.92 | ALDH1A1 (0.58) | ALDH1A1CYP2C9KDM4ETDP1SMN1; SMN2 | |
| SCHEMBL18798785 | 0.89 | ALDH1A1 (0.55) | ALDH1A1CYP2C9KDM4ETDP1SMN1; SMN2 | |
| SCHEMBL17153744 | 0.88 | ALDH1A1 (0.55) | ALDH1A1CYP2C9KDM4ETDP1SMN1; SMN2 | |
| SCHEMBL5590925 | 0.84 | ALDH1A1 (0.58) | ALDH1A1CYP2C9KDM4ETDP1SMN1; SMN2 | |
| SCHEMBL10491778 | 0.84 | ALDH1A1 (0.58) | ALDH1A1CYP2C9KDM4ETDP1SMN1; SMN2 | |
| SCHEMBL355357 | 0.84 | ALDH1A1 (0.59) | ALDH1A1CYP2C9KDM4ETDP1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL1375604 | 0.82 | ALDH1A1 (0.62) | ALDH1A1CYP2C9KDM4ETDP1SMN1; SMN2 | |
| SCHEMBL21326417 | 0.82 | SMN1; SMN2 (0.55) | ALDH1A1CYP2C9KDM4ETDP1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115084518-B | Negative electrode binder and application thereof | 清华大学深圳国际研究生院 | 2024-11-01 | — | — | CN | claimed |
| CN-115084518-A | Negative electrode binder and application thereof | 清华大学深圳国际研究生院 | 2022-09-20 | — | — | CN | claimed |
| CN-114409895-A | Semi-aromatic polyamide and preparation method and application thereof | 重庆沃特智成新材料科技有限公司 | 2022-04-29 | — | — | CN | claimed |
| EP-3965657-A1 | MEDIATION OF IN VIVO ANALYTE SIGNAL DEGRADATION | Senseonics, Incorporated (US) | 2022-03-16 | — | — | EP | claimed |
| WO-2003099852-A2 | PEPTIDE DERIVATIZATION PROCESS | RESTORAGEN INC. (US) | 2003-12-04 | — | — | WO | claimed |
| EP-1280866-A1 | ACTIVATOR COMPOSITIONS FOR CYANOACRYLATE ADHESIVES | Loctite (R & D) Limited (IE) | 2003-02-05 | — | — | EP | claimed |
| WO-2001085861-A1 | ACTIVATOR COMPOSITIONS FOR CYANOACRYLATE ADHESIVES | LOCTITE (R & D) LIMITED (IE) | 2001-11-15 | — | — | WO | claimed |
| US-4378364-A | DITHIOBIS(PYRIDINE-CARBOXYLIC ACID) TO RELIEVE PAIN, INCREASE APPETITE | GRASSETTI DAVIDE R | 1983-03-29 | — | — | US | claimed |
| US-4152439-A | 6,6-DITHIODINICOTINIC ACID, ESTER OR ALKALI METAL OR AMMONIUM SALT | Grassetti, Davide R. (US) | 1979-05-01 | — | — | US | claimed |
| EP-4577189-A1 | MUCOADHESIVE PHARMACEUTICAL DOSAGE FORM FOR UNIDIRECTIONAL RELEASE OF PEPTIDE THERAPEUTIC PARTICLES | The University of British Columbia (CA) | 2025-07-02 | — | — | EP | disclosed |
| US-20240173262-A1 | MUCOADHESIVE PHARMACEUTICAL DOSAGE FORM FOR UNIDIRECTIONAL RELEASE OF PEPTIDE THERAPEUTIC PARTICLES | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2024-05-30 | — | — | US | disclosed |
| WO-2024040356-A1 | MUCOADHESIVE PHARMACEUTICAL DOSAGE FORM FOR UNIDIRECTIONAL RELEASE OF PEPTIDE THERAPEUTIC PARTICLES | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2024-02-29 | — | — | WO | disclosed |
| WO-2024040356-A1 | MUCOADHESIVE PHARMACEUTICAL DOSAGE FORM FOR UNIDIRECTIONAL RELEASE OF PEPTIDE THERAPEUTIC PARTICLES | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2024-02-29 | — | — | WO | disclosed |
| US-11680946-B1 | Detection of cholinesterase inhibition with microfluidic devices and systems thereof | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC (US) | 2023-06-20 | — | — | US | disclosed |
| US-5266560-A | Glucose tolerance factor | THOMAS RESEARCH CORPORATION (US) | 1993-11-30 | — | — | US | disclosed |
| EP-0552376-A1 | PRODUCTION OF POLYMER HYDROXYLATED AT BOTH TERMINALS, COMPOSITION CONTAINING SAID POLYMER AND ITS USE, AND POLYMER DERIVED FROM SAID COMPOSITION AND ITS USE | NIPPON SHOKUBAI CO., LTD. (JP) | 1993-07-28 | — | — | EP | disclosed |
| US-4957640-A | Corrosion prevention with compositions prepared from organic fatty amines and nitrogen-containing aromatic heterocyclic compounds | THE DOW CHEMICAL COMPANY (US) | 1990-09-18 | — | — | US | disclosed |
| US-4765839-A | PAVING | THE DOW CHEMICAL COMPANY (US) | 1988-08-23 | — | — | US | disclosed |
| US-4761473-A | CORROSION RESISTANCE OF OIL OR GAS WELLS | THE DOW CHEMICAL COMPANY (US) | 1988-08-02 | — | — | US | disclosed |
| US-4152439-A | 6,6-DITHIODINICOTINIC ACID, ESTER OR ALKALI METAL OR AMMONIUM SALT | Grassetti, Davide R. (US) | 1979-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240173262-A1 | MUCOADHESIVE PHARMACEUTICAL DOSAGE FORM FOR UNIDIRECTIONAL RELEASE OF PEPTIDE THERAPEUTIC PARTICLES | GLP1R, IAPP, GIPR | ALDH1A1 4462/4885CYP2C9 2287/4885KDM4E 4582/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.